- Indoco Remedies Ltd
-
INDOCO Stock View
(NSE)
353.05
Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The Company is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company's geographical segments include India and Outside India. The Company has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.
Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.
-
376.91
-
373.71
-
391.73